Asmar L - Search Results

1

Randomized phase III study of trastuzumab, paclitaxel, and carboplatin compared with trastuzumab and paclitaxel in women with HER-2-overexpressing metastatic breast cancer.

Robert N, Leyland-Jones B, Asmar L, Belt R, Ilegbodu D, Loesch D, Raju R, Valentine E, Sayre R, Cobleigh M, Albain K, McCullough C, Fuchs L, Slamon D. Robert N, et al. Among authors: asmar l. J Clin Oncol. 2006 Jun 20;24(18):2786-92. doi: 10.1200/JCO.2005.04.1764. J Clin Oncol. 2006. PMID: 16782917 Clinical Trial.

2

Effectiveness of mastectomy by response to induction chemotherapy for control in inflammatory breast carcinoma.

Fleming RY, Asmar L, Buzdar AU, McNeese MD, Ames FC, Ross MI, Singletary SE. Fleming RY, et al. Among authors: asmar l. Ann Surg Oncol. 1997 Sep;4(6):452-61. doi: 10.1007/BF02303668. Ann Surg Oncol. 1997. PMID: 9309333

3

Impact of selection process on response rate and long-term survival of potential high-dose chemotherapy candidates treated with standard-dose doxorubicin-containing chemotherapy in patients with metastatic breast cancer.

Rahman ZU, Frye DK, Buzdar AU, Smith TL, Asmar L, Champlin RE, Hortobagyi GN. Rahman ZU, et al. Among authors: asmar l. J Clin Oncol. 1997 Oct;15(10):3171-7. doi: 10.1200/JCO.1997.15.10.3171. J Clin Oncol. 1997. PMID: 9336352

4

Prospective randomized trial of paclitaxel alone versus 5-fluorouracil/doxorubicin/cyclophosphamide as induction therapy in patients with operable breast cancer.

Buzdar AU, Hortobagyi GN, Asmar L, Theriault RL, Rahman Z, McNeese M, Singletary S, Ames F. Buzdar AU, et al. Among authors: asmar l. Semin Oncol. 1997 Oct;24(5 Suppl 17):S17-31-S17-34. Semin Oncol. 1997. PMID: 9374089 Clinical Trial.

5

Results and long term follow-up for 1581 patients with metastatic breast carcinoma treated with standard dose doxorubicin-containing chemotherapy: a reference.

Rahman ZU, Frye DK, Smith TL, Asmar L, Theriault RL, Buzdar AU, Hortobagyi GN. Rahman ZU, et al. Among authors: asmar l. Cancer. 1999 Jan 1;85(1):104-11. doi: 10.1002/(sici)1097-0142(19990101)85:1<104::aid-cncr15>3.0.co;2-r. Cancer. 1999. PMID: 9921981

6

Estrogen replacement therapy after localized breast cancer: clinical outcome of 319 women followed prospectively.

Vassilopoulou-Sellin R, Asmar L, Hortobagyi GN, Klein MJ, McNeese M, Singletary SE, Theriault RL. Vassilopoulou-Sellin R, et al. Among authors: asmar l. J Clin Oncol. 1999 May;17(5):1482-7. doi: 10.1200/JCO.1999.17.5.1482. J Clin Oncol. 1999. PMID: 10334534 Clinical Trial.

7

Paclitaxel by 24-hour infusion with doxorubicin by 48-hour infusion as initial therapy for metastatic breast cancer: phase I results.

Holmes FA, Valero V, Walters RS, Theriault RL, Booser DJ, Gibbs H, Fraschini G, Buzdar AU, Willey J, Frye D, Asmar L, Hortobagyi GN. Holmes FA, et al. Among authors: asmar l. Ann Oncol. 1999 Apr;10(4):403-11. doi: 10.1023/a:1008360406322. Ann Oncol. 1999. PMID: 10370782 Free article. Clinical Trial.

8

Relapse after complete response to anthracycline-based combination chemotherapy in metastatic breast cancer.

Pusztai L, Asmar L, Smith TL, Hortobagyi GN. Pusztai L, et al. Among authors: asmar l. Breast Cancer Res Treat. 1999 May;55(1):1-8. doi: 10.1023/a:1006161906667. Breast Cancer Res Treat. 1999. PMID: 10472774

9

Prospective evaluation of paclitaxel versus combination chemotherapy with fluorouracil, doxorubicin, and cyclophosphamide as neoadjuvant therapy in patients with operable breast cancer.

Buzdar AU, Singletary SE, Theriault RL, Booser DJ, Valero V, Ibrahim N, Smith TL, Asmar L, Frye D, Manuel N, Kau SW, McNeese M, Strom E, Hunt K, Ames F, Hortobagyi GN. Buzdar AU, et al. Among authors: asmar l. J Clin Oncol. 1999 Nov;17(11):3412-7. doi: 10.1200/JCO.1999.17.11.3412. J Clin Oncol. 1999. PMID: 10550135 Clinical Trial.

10

Long-term results of combined-modality therapy for locally advanced breast cancer with ipsilateral supraclavicular metastases: The University of Texas M.D. Anderson Cancer Center experience.

Brito RA, Valero V, Buzdar AU, Booser DJ, Ames F, Strom E, Ross M, Theriault RL, Frye D, Kau SW, Asmar L, McNeese M, Singletary SE, Hortobagyi GN. Brito RA, et al. Among authors: asmar l. J Clin Oncol. 2001 Feb 1;19(3):628-33. doi: 10.1200/JCO.2001.19.3.628. J Clin Oncol. 2001. PMID: 11157012 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

121 results

Search Page

Filters